Recomendaciones actualizadas | 12 NOV 12

Diagnóstico y tratamiento de la faringitis por Streptococcus grupo A

La guía actualiza las recomendaciones de la Infectious Diseases Society of America destinadas a los profesionales de la salud que atienden pacientes adultos y pediátricos con faringitis SGA.
Autor/a: Dres. Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Van Beneden C. Clin Infect Dis. 2012 Sep 9.
INDICE:  1. Artículo | 2. Referencias


1. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group a streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis 2002; 35:113–25.
2. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336:924–6.
3. Guyatt GH, Oxman AD, Kunz R, et al. Going from evidence to recommendations. BMJ 2008; 336:1049–51.
4. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is “quality of evidence” and why is it important to clinicians? BMJ 2008; 336:995–8.
5. Jaeschke R, Guyatt GH, Dellinger P, et al. Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ 2008; 337:a744.
6. Schunemann HJ, Oxman AD, Brozek J, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 2008; 336:1106–10.
7. Kish MA. Guide to development of practice guidelines. Clin Infect Dis 2001; 32:851–4.
8. Chow AW, Benninger MS, Brook I, et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis 2012; 54:e72–112.
9. Bisno AL. Acute pharyngitis: etiology and diagnosis. Pediatrics 1996; 97:949–54.
10. Ebell MH, Smith MA, Barry HC, Ives K, Carey M. The rational clinical examination. Does this patient have strep throat? JAMA 2000; 284:2912–8.
11. Lindbaek M, Francis N, Cannings-John R, Butler CC, Hjortdahl P. Clinical course of suspected viral sore throat in young adults: cohort study. Scand J Prim Health Care 2006; 24:93–7.
12. Wannamaker LW. Perplexity and precision in the diagnosis of streptococcal pharyngitis. Am J Dis Child 1972; 124:352–8.
13. Linder JA, Bates DW, Lee GM, Finkelstein JA. Antibiotic treatment of children with sore throat. JAMA 2005; 294:2315–22.
14. Linder JA, Chan JC, Bates DW. Evaluation and treatment of pharyngitis in primary care practice: the difference between guidelines is largely academic. Arch Intern Med 2006; 166:1374–9.
15. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 2002; 287:3096–102.
16. Pfoh E, Wessels MR, Goldmann D, Lee GM. Burden and economic cost of group A streptococcal pharyngitis. Pediatrics 2008; 121:229–34.
17. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group a streptococcal diseases. Lancet Infect Dis 2005; 5:685–94.
18. Field MJL, Kathleen N. Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines. Clinical practice guidelines: directions for a new program. Washington, DC:National Academy Press, 1990:52–77.
19. Breese BB. A simple scorecard for the tentative diagnosis of streptococcal pharyngitis. Am J Dis Child 1977; 131:514–7.
20. McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA 2004; 291:1587–95.
21. Poses RM, Cebul RD, Collins M, Fager SS. The accuracy of experienced physicians’ probability estimates for patients with sore throats. implications for decision making. JAMA 1985; 254:925–9.
22. Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making 1981; 1:239–46.
23. Kaplan EL, Top FH Jr, Dudding BA, Wannamaker LW. Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child. J Infect Dis 1971; 123:490–501.
24. Hustedt JW, Vazquez M. The changing face of pediatric respiratory tract infections: how human metapneumovirus and human bocavirus fit into the overall etiology of respiratory tract infections in young children. Yale J Biol Med 2010; 83:193–200.
25. Mackenzie A, Fuite LA, Chan FT, et al. Incidence and pathogenicity of Arcanobacterium haemolyticum during a 2-year study in Ottawa. Clin Infect Dis 1995; 21:177–81.
26. Nyman M, Alugupalli KR, Stromberg S, Forsgren A. Antibody response to Arcanobacterium haemolyticum infection in humans. J Infect Dis 1997; 175:1515–8.
27. Cimolai N, Elford RW, Bryan L, Anand C, Berger P. Do the betahemolytic non-group A streptococci cause pharyngitis? Rev Infect Dis 1988; 10:587–601.
28. Turner JC, Hayden FG, Lobo MC, Ramirez CE, Murren D. Epidemiologic evidence for Lancefield group C beta-hemolytic streptococci as a cause of exudative pharyngitis in college students. J Clin Microbiol 1997; 35:1–4.
29. Meier FA, Centor RM, Graham L Jr, Dalton HP. Clinical and microbiological evidence for endemic pharyngitis among adults due to group C streptococci. Arch Intern Med 1990; 150:825–9.
30. Gerber MA, Randolph MF, Martin NJ, et al. Community-wide outbreak of group G streptococcal pharyngitis. Pediatrics 1991; 87:598–603.
31. Amess JA, O’Neill W, Giollariabhaigh CN, Dytrych JK. A six-month audit of the isolation of Fusobacterium necrophorum from patients with sore throat in a district general hospital. Br J Biomed Sci 2007;64:63–5.
32. Jensen A, Hagelskjaer Kristensen L, Prag J. Detection of Fusobacterium necrophorum subsp. funduliforme in tonsillitis in young adults by real-time PCR. Clin Microbiol Infect 2007; 13:695–701.
33. Batty A, Wren MW, Gal M. Fusobacterium necrophorum as the cause of recurrent sore throat: comparison of isolates from persistent sore throat syndrome and Lemierre’s disease. J Infect 2005; 51:299–306.
34. Centor RM, Geiger P, Waites KB. Fusobacterium necrophorum bacteremic tonsillitis: 2 cases and a review of the literature. Anaerobe 2010; 16:626–8.
35. Riordan T. Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre’s syndrome. Clin Microbiol Rev 2007; 20:622–59.
36. Snow V, Mottur-Pilson C, Cooper RJ, Hoffman JR. Principles of appropriate antibiotic use for acute pharyngitis in adults. Ann Intern Med 2001; 134:506–8.
37. Gerber MA. Diagnosis of pharyngitis: methodology of throat cultures. In: Shulman ST, ed. Pharyngitis: management in an era of declining rheumatic fever. New York: Praeger, 1984:61–72.
38. Gerber MA. Comparison of throat cultures and rapid strep tests for diagnosis of streptococcal pharyngitis. Pediatr Infect Dis J 1989; 8:820–4.
39. Schwartz RH, Gerber MA, McCoy P. Effect of atmosphere of incubation on the isolation of group A streptococci from throat cultures. J Lab Clin Med 1985; 106:88–92.
40. Brien JH, Bass JW. Streptococcal pharyngitis: optimal site for throat culture. J Pediatr 1985; 106:781–3.
41. Kellogg JA. Suitability of throat culture procedures for detection of group A streptococci and as reference standards for evaluation of streptococcal antigen detection kits. J Clin Microbiol 1990; 28:165–9.
42. Randolph MF, Gerber MA, DeMeo KK, Wright L. Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J Pediatr 1985; 106:870–5.
43. Gerber MA, Shulman ST. Rapid diagnosis of pharyngitis caused by group A streptococci. Clin Microbiol Rev 2004; 17:571–80.
44. Tanz RR, Gerber MA, Kabat W, Rippe J, Seshadri R, Shulman ST. Performance of a rapid antigen-detection test and throat culture in community pediatric offices: implications for management of pharyngitis. Pediatrics 2009; 123:437–44.
45. Johnson DR, Kaplan EL. False-positive rapid antigen detection test results: reduced specificity in the absence of group A streptococci in the upper respiratory tract. J Infect Dis 2001; 183:1135–7.
46. Nyquist AC, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA 1998; 279:875–7.
47. Shet A, Kaplan EL. Clinical use and interpretation of group a streptococcal antibody tests: a practical approach for the pediatrician or primary care physician. Pediatr Infect Dis J 2002; 21:420–6; quiz 27–30.
48. Johnson DR, Kurlan R, Leckman J, Kaplan EL. The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications. Clin Infect Dis 2010; 50:481–90.
49. Wald ER, Green MD, Schwartz B, Barbadora K. A streptococcal score card revisited. Pediatr Emerg Care 1998; 14:109–11.
50. Kaplan EL. The group A streptococcal upper respiratory tract carrier state: an enigma. J Pediatr 1980; 97:337–45.
51. Report of the Committee on Infectious Disease. Pickering LK, editor. 29th Edition, Group A Streptococcal Infections. Elk Grove Village, IL: American Academy of Pediatrics, 2012:668–80.
52. Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 1995; 96:758–64.
53. Wannamaker LW, Rammelkamp CH Jr, Denny FW, et al. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. Am J Med 1951; 10:673–95.
54. Rammelkamp CH Jr. Glomerulonephritis. Proc Inst Med Chic 1953; 19:371–84.
55. Komaroff AL, Pass TM, Aronson MD, et al. The prediction of streptococcal pharyngitis in adults. J Gen Intern Med 1986; 1:1–7.
56. Bisno AL. Acute pharyngitis. N Engl J Med 2001; 344:205–11.
57. Cooper RJ, Hoffman JR, Bartlett JG, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med 2001; 134:509–17.
58. Humair JP, Revaz SA, Bovier P, Stalder H. Management of acute pharyngitis in adults: reliability of rapid streptococcal tests and clinical findings. Arch Intern Med 2006; 166:640–4.
59. Boisvert PL, Darrow D, Powers GF, et al. Streptococci in children. Am J Dis Child 1942; 64:516–34.
60. Shaikh N, Leonard E, Martin JM. Prevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysis. Pediatrics 2010; 126:e557–64.
61. Nussinovitch M, Finkelstein Y, Amir J, Varsano I. Group A beta-hemolytic streptococcal pharyngitis in preschool children aged 3 months to 5 years. Clin Pediatr (Phila) 1999; 38:357–60.
62. Amir J, Shechter Y, Eilam N, Varsano I. Group A beta-hemolytic streptococcal pharyngitis in children younger than 5 years. Isr J Med Sci 1994; 30:619–22.
63. Rimoin AW, Hamza HS, Vince A, et al. Evaluation of the WHO clinical decision rule for streptococcal pharyngitis. Arch Dis Child 2005;90:1066–70.
64. Tani LY, Veasy LG, Minich LL, Shaddy RE. Rheumatic fever in children younger than 5 years: is the presentation different? Pediatrics 2003; 112:1065–8.
65. Gordis L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. T. Duckett Jones Memorial Lecture. Circulation 1985; 72:1155–62.
66. Ramanan PV, Premkumar S, Ramnath B. Youngest patient with Sydenham’s chorea: a case report. J Indian Med Assoc 2009; 107:246, 53.
67. Vinker S, Zohar E, Hoffman R, Elhayany A. Incidence and clinical manifestations of rheumatic fever: a 6 year community-based survey. Isr Med Assoc J 2010; 12:78–81.
68. Paulo LT, Terreri MT, Barbosa CM, Len CA, Hilario MO. [Is rheumatic fever a more severe disease in pre-school children?]. Acta Reumatol Port 2009; 34:66–70.
69. Ramanan PV, Anand K. Post varicella thrombosis. Indian Pediatr 2009; 46:538–9.
70. Ellis NM, Kurahara DK, Vohra H, et al. Priming the immune system for heart disease: a perspective on group A streptococci. J Infect Dis 2010; 202:1059–67. IDSA Guideline for GAS Pharyngitis • CID • 15
 71. James WE, Badger GF, Dingle JH. A study of illness in a group of Cleveland families. XIX. The epidemiology of the acquisition of group A streptococci and of associated illnesses. N Engl J Med 1960; 262:687–94.
72. Gastanaduy AS, Kaplan EL, Huwe BB, McKay C, Wannamaker LW. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. Lancet 1980; 2:498–502.
73. Dingle JH, Badger G, Jordan WS Jr. Illness in the home. Cleveland: Case Western Reserve University Press, 1964:97–119.
74. Musher DM. How contagious are common respiratory tract infections? N Engl J Med 2003; 348:1256–66.
75. Brink WR, Rammelkamp CH Jr, Denny FW, Wannamaker LW. Effect in penicillin and aureomycin on the natural course of streptococcal tonsillitis and pharyngitis. Am J Med 1951; 10:300–8.
76. Zwart S, Rovers MM, de Melker RA, Hoes AW. Penicillin for acute sore throat in children: randomised, double blind trial. BMJ 2003;327:1324.
77. Middleton DB, D’Amico F, Merenstein JH. Standardized symptomatic treatment versus penicillin as initial therapy for streptococcal pharyngitis. J Pediatr 1988; 113:1089–94.
78. Peter G, Smith AL. Group A streptococcal infections of the skin and pharynx (second of two parts). N Engl J Med 1977; 297:365–70.
79. Peter G, Smith AL. Group A streptococcal infections of the skin and pharynx (first of two parts). N Engl J Med 1977; 297:311–7.
80. Del Mar CB, Glasziou PP, Spinks AB. Antibiotics for sore throat. Cochrane Database Syst Rev 2006:CD000023.
81. Tanz RR, Shulman ST, Barthel MJ, Willert C, Yogev R. Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci. J Pediatr 1985; 106:876–80.
82. Kaplan EL, Gooch IW, Notario GF, Craft JC. Macrolide therapy of group A streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than 5 days (azithromycin). Clin Infect Dis 2001; 32:1798–802.
83. Klein JO. Management of streptococcal pharyngitis. Pediatr Infect Dis J 1994; 13:572–5.
84. Kikuta H, Shibata M, Nakata S, et al. Efficacy of antibiotic prophylaxis for intrafamilial transmission of group A beta-hemolytic streptococci. Pediatr Infect Dis J 2007; 26:139–41.
85. El Kholy A, Fraser DW, Guirguis N, Wannamaker LW, Plikaytis BD, Zimmerman RA. A controlled study of penicillin therapy of group A streptococcal acquisitions in Egyptian families. J Infect Dis 1980;141:759–71.
86. No authors listed. Rheumatic fever and rheumatic heart disease. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1988; 764:1–58.
87. Shulman ST, Gerber MA, Tanz RR, Markowitz M. Streptococcal pharynx itis: the case for penicillin therapy. Pediatr Infect Dis J 1994; 13:1–7.
88. Feder HM Jr, Gerber MA, Randolph MF, Stelmach PS, Kaplan EL. Once-daily therapy for streptococcal pharyngitis with amoxicillin. Pediatrics 1999; 103:47–51.
89. Gerber MA, Tanz RR. New approaches to the treatment of group A streptococcal pharyngitis. Curr Opin Pediatr 2001; 13:51–5.
90. Clegg HW, Ryan AG, Dallas SD, et al. Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin: a noninferiority trial. Pediatr Infect Dis J 2006; 25:761–7.
91. Lennon DR, Farrell E, Martin DR, Stewart JM. Once-daily amoxicillin versus twice-daily penicillin V in group A beta-haemolytic streptococcal pharyngitis. Arch Dis Child 2008; 93:474–8.
92. Shvartzman P, Tabenkin H, Rosentzwaig A, Dolginov F. Treatment of streptococcal pharyngitis with amoxycillin once a day. BMJ 1993;306:1170–2.
93. Tack KJ, Hedrick JA, Rothstein E, Nemeth MA, Keyserling C, Pichichero ME. A study of 5-day cefdinir treatment for streptococcal pharyngitis in children. Cefdinir Pediatric Pharyngitis Study Group. Arch Pediatr Adolesc Med 1997; 151:45–9.
94. Tack KJ, Henry DC, Gooch WM, Brink DN, Keyserling CH. Fiveday cefdinir treatment for streptococcal pharyngitis. Cefdinir Pharyngitis Study Group. Antimicrob Agents Chemother 1998; 42:1073–5.
95. Pichichero ME, Gooch WM, Rodriguez W, et al. Effective shortcourse treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis. Ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children. Arch Pediatr Adolesc Med 1994;148:1053–60.
96. Portier H, Chavanet P, Waldner-Combernoux A, et al. Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin. Scand J Infect Dis 1994; 26:59–66.
97. Hooton TM. A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis. Am J Med 1991; 91:23S–6S.
98. Gerber MA. Antibiotic resistance in group A streptococci. Pediatr Clin North Am 1995; 42:539–51.
99. Coonan KM, Kaplan EL. In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics. Pediatr Infect Dis J 1994; 13:630–5.
100. Wickman PA, Black JA, Moland ES, Thomson KS. In vitro activities of DX-619 and comparison quinolones against gram-positive cocci. Antimicrob Agents Chemother 2006; 50:2255–7.
101. Wilcox MH. The tide of antimicrobial resistance and selection. Int J Antimicrob Agents 2009; 34(Suppl 3):S6–10.
102. Colodner R, Rock W, Chazan B, et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 2004;23:163–7.
103. Pichichero ME. A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics 2005; 115:1048–57.
104. Tanz RR, Shulman ST, Shortridge VD, et al. Community-based surveillance in the united states of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons. Clin Infect Dis 2004; 39:1794–801.
105. Seppala H, Nissinen A, Jarvinen H, et al. Resistance to erythromycin in group A streptococci. N Engl J Med 1992; 326:292–7.
106. Schachtel BP, Thoden WR. A placebo-controlled model for assaying systemic analgesics in children. Clin Pharmacol Ther 1993; 53:593–601.
107. Gehanno P, Dreiser RL, Ionescu E, Gold M, Liu JM. Lowest effective single dose of diclofenac for antipyretic and analgesic effects in acute febrile sore throat. Clin Drug Investig 2003; 23:263–71.
108. Bertin L, Pons G, d’Athis P, et al. Randomized, double-blind, multicenter, controlled trial of ibuprofen versus acetaminophen (paracetamol) and placebo for treatment of symptoms of tonsillitis and pharyngitis in children. J Pediatr 1991; 119:811–4.
109. McNally D, Simpson M, Morris C, Shephard A, Goulder M. Rapid relief of acute sore throat with AMC/DCBA throat lozenges: randomized controlled trial. Int J Clin Pract 2010; 64:194–207.
110. Olympia RP, Khine H, Avner JR. Effectiveness of oral dexamethasone in the treatment of moderate to severe pharyngitis in children. Arch Pediatr Adolesc Med 2005; 159:278–82.
111. Bulloch B, Kabani A, Tenenbein M. Oral dexamethasone for the treatment of pain in children with acute pharyngitis: a randomized, double-blind, placebo-controlled trial. Ann Emerg Med 2003;41:601–8.
112. Wing A, Villa-Roel C, Yeh B, Eskin B, Buckingham J, Rowe BH. Effectiveness of corticosteroid treatment in acute pharyngitis: a systematic review of the literature. Acad Emerg Med 2010; 17:476–83.
113. Thomas M, Del Mar C, Glasziou P. How effective are treatments other than antibiotics for acute sore throat? Br J Gen Pract 2000;50:817–20.
114. Gerber MA, Tanz RR, Kabat W, et al. Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics 1999; 104:911–7.
115. Martin JM, Green M, Barbadora KA, Wald ER. Group A streptococci among school-aged children: clinical characteristics and the carrier state. Pediatrics 2004; 114:1212–9.
116. Kaplan EL, Gastanaduy AS, Huwe BB. The role of the carrier in treatment failures after antibiotic for group A streptococci in the upper respiratory tract. J Lab Clin Med 1981; 98:326–35.
117. Shulman ST. Streptococcal pharyngitis: diagnostic considerations. Pediatr Infect Dis J 1994; 13:567–71.
118. Chaudhary S, Bilinsky SA, Hennessy JL, et al. Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: a randomized trial of 10 days penicillin vs 10 days penicillin with rifampin during the final 4 days of therapy. J Pediatr 1985; 106:481–6.
119. Tanz RR, Poncher JR, Corydon KE, Kabat K, Yogev R, Shulman ST. Clindamycin treatment of chronic pharyngeal carriage of group A streptococci. J Pediatr 1991; 119:123–8.
120. Kaplan EL, Johnson DR. Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. J Pediatr 1988; 113:400–3.
121. Paradise JL, Bluestone CD, Bachman RZ, et al. Efficacy of tonsillectomy for recurrent throat infection in severely affected children. Results of parallel randomized and nonrandomized clinical trials. N Engl J Med 1984; 310:674–83.
122. Paradise JL, Bluestone CD, Colborn DK, Bernard BS, Rockette HE, Kurs-Lasky M. Tonsillectomy and adenotonsillectomy for recurrent throat infection in moderately affected children. Pediatrics 2002; 110:7–15.
123. Discolo CM, Darrow DH, Koltai PJ. Infectious indications for tonsillectomy. Pediatr Clin North Am 2003; 50:445–58.
124. Baugh RF, Archer SM, Mitchell RB, et al. Clinical practice guideline: tonsillectomy in children. Otolaryngol Head Neck Surg 2011; 144:S1–30.
125. Bass JW, Person DA, Chan DS. Twice-daily oral penicillin for treatment of streptococcal pharyngitis: less is best. Pediatrics 2000; 105:423–4.
126. Gerber MA, Spadaccini LJ, Wright LL, Deutsch L, Kaplan EL. Twicedaily penicillin in the treatment of streptococcal pharyngitis. Am J Dis Child 1985; 139:1145–8.
127. Bass JW, Crast FW, Knowles CR, Onufer CN. Streptococcal pharyngitis in children. A comparison of four treatment schedules with intramuscular penicillin G benzathine. JAMA 1976;235:1112–6.
128. Stillerman M, Isenberg HD. Streptococcal pharyngitis therapy: comparison of cyclacillin, cephalexin, and potassium penicillin V. Antimicrob Agents Chemother (Bethesda) 1970; 10:270–6.
129. Stillerman M, Isenberg HD, Moody M. Streptococcal pharyngitis therapy. Comparison of cephalexin, phenoxymethyl penicillin, and ampicillin. Am J Dis Child 1972; 123:457–61.
130. Disney FA, Dillon H, Blumer JL, et al. Cephalexin and penicillin in the treatment of group A beta-hemolytic streptococcal throat infections. Am J Dis Child 1992; 146:1324–7.
131. Disney FA, Breese BB, Green JL, Talpey WB, Tobin JR. Cephalexin and penicillin therapy of childhood beta-hemolytic streptococcal infections. Postgrad Med J 1971; 47(Suppl):47–51.
132. Gerber MA, Randolph MF, Chanatry J, Wright LL, Anderson LR, Kaplan EL. Once daily therapy for streptococcal pharyngitis with cefadroxil. J Pediatr 1986; 109:531–7.
133. Jackson H. Prevention of rheumatic fever. A comparative study of clindamycin palmitate and ampicillin in the treatment of group A beta hemolytic streptococcal pharyngitis. Clin Pediatr (Phila) 1973;12:501–3.
134. Kafetzis DA, Liapi G, Tsolia M, et al. Failure to eradicate Group A beta-haemolytic streptococci (GABHS) from the upper respiratory tract after antibiotic treatment. Int J Antimicrob Agents 2004;23:67–71.



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024